Takeda Pharmaceutical Company Limited (TKPHF.PK) Thursday said its profit for the 9-month period declined nearly 50 percent to 147.1 billion yen or 94 yen per share from last year.
Excluding one-time items, core profit was 643.6 billion yen, or 412 yen per share, nearly 9 percent down from the year-ago period.
Revenue for the period, however, rose 4.6% to 3,212.9 billion yen from the previous year.
Looking forward, the company has maintained in full-year outlook for revenue of 3,980 billion yen and core EPS of 447 yen per share.
For comments and feedback: editorial@rttnews.com